Status:
RECRUITING
Online Interplay Between Deciding and Acting With Mild Cognitive Impairment
Lead Sponsor:
University of Delaware
Collaborating Sponsors:
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Conditions:
Mild Cognitive Impairment
Eligibility:
All Genders
45-90 years
Phase:
NA
Brief Summary
The investigators aim to understand the interplay and neural structures involved with decision--making and movement for participants with mild cognitive impairment. Rapidly deciding and acting becomes...
Detailed Description
Mild cognitive impairment leads not only to impaired decision making, but also movement deficits that predict the development of Alzheimer's disease. Recent behavioral work has suggested a common mech...
Eligibility Criteria
Inclusion
- age 45 - 90 years
- Perfect or corrected vision
- Ability to reach
- Neurotypical Age-Matched control participants - No history of neurological disorders or injury.
- Mild Cognitive Impairment participants - clinical diagnosis of amnestic mild cognitive impairment.
Exclusion
- Any injury or condition that impacts reaching
- Traumatic brain injury, such as concussion, in the last 6 months.
- Neurotypical Age-Matched control participants: Modified Telephone Interview for Cognitive Status (TICS-m) score \< 34
- Mild Cognitive Impairment participants: Modified Telephone Interview for Cognitive Status (TICS-m) score \> 34
- Mild Cognitive Impairment participants: Mini-Mental State Examination Second Edition (MMSE-2) score \< 21.
Key Trial Info
Start Date :
January 28 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06493422
Start Date
January 28 2025
End Date
June 30 2026
Last Update
October 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Delaware
Newark, Delaware, United States, 19713